Celldex Therapeutics, Inc. is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.
View all → Recent Releases
More →Upcoming Events
|Details on upcoming events are not yet available.|
Featured Financial Reports
|Nov 5, 2015||Form 10-Q||330.4 KB|
|Feb 25, 2016||Form 10-K/A||1.1 MB|